Status:
COMPLETED
Intravenous Dexmedetomidine in Cesarean Section Under Spinal Anesthesia
Lead Sponsor:
Egyptian Biomedical Research Network
Conditions:
Cesarean Section Complications
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
The present study hypothesized that intravenous dexmedetomidine use during spinal anesthesia for cesarean section has a beneficial influence on hemodynamic stability and epigastric pain together with ...
Detailed Description
Background and aim: Hypotension and epigastric pain are commonly encountered during spinal anesthesia for cesarean section. Dexmedetomidine (DEX) is a highly selective α 2-adrenergic agonist. Its effe...
Eligibility Criteria
Inclusion
- Full-term pregnancy and American Society of Anesthesiologists (ASA) physical status I/II in women scheduled for elective cesarean section
Exclusion
- Severe hepatic or renal disease
- Severe cardiopulmonary disease
- Thyroid disorders multiple allergies prematurity
- Known fatal abnormality
- Known chronic gastrointestinal problems with epigastric pain e.g. peptic ulcer and reflux esophagitis.
Key Trial Info
Start Date :
May 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04358367
Start Date
May 19 2019
End Date
November 19 2019
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar University Faculty of Medicine
Cairo, Egypt